XML 21 R6.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net income: $ 45,480 $ 26,661 $ 31,602
Other comprehensive income (loss):      
Interest rate swap (836) (336)  
Interest rate swap - unconsolidated affiliate (821)    
Reclassification of net realized (gain) loss included in earnings (4) (69) 1,061
Reclassification into retained earnings [1]     932
Reclassification of other-than-temporary impairment loss included in earnings     2,330
Total before income taxes (1,523) 455 1,472
Income tax benefit (expense) [2] 386 (116) (685)
Total other comprehensive (loss) income, net of tax (1,137) 339 787
Total comprehensive income, net of tax 44,343 27,000 32,389
Total comprehensive (income) loss attributable to non-controlling interest (277) 114 767
Total comprehensive income attributable to the Company 44,066 27,114 33,156
Unrestricted available-for-sale, Debt securities      
Other comprehensive income (loss):      
Net unrealized gain (loss) on investments 130 842 (2,845)
Restricted      
Other comprehensive income (loss):      
Net unrealized gain (loss) on investments $ 8 $ 18 $ (6)
[1] The reclassification into retained earnings for the year ended December 31, 2018 relates to the adoption of ASU 2016-01 Financial Instruments – Overall, as amended (“ASU 2016-01”). The new guidance was effective January 1, 2018, and required equity investments to be measured at fair value with changes in fair value recognized in results of operations rather than the consolidated statements of comprehensive income.
[2] Income tax benefit (expense) for the year ended December 31, 2018 includes $0.3 million of income tax expense related to the adoption of ASU 2018-02 Income Statement – Reporting Comprehensive Income (“ASU 2018-02”). The new guidance was effective January 1, 2018, and allowed a reclassification from accumulated other comprehensive loss to retained earnings for stranded tax effects resulting from the Tax Act.